{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:35:20Z","timestamp":1788910520663,"version":"build-2803163510"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>In this study we analyzed gene co-expression networks of three immune-related skin diseases: cutaneous sarcoidosis (CS), discoid lupus erythematosus (DLE), and psoriasis. We propose that investigation of gene co-expression networks may provide insights into underlying disease mechanisms. Microarray expression data from two cohorts of patients with CS, DLE, or psoriasis skin lesions were analyzed. We applied weighted gene correlation network analysis (WGCNA) to construct gene-gene similarity networks and cluster genes into modules based on similar expression profiles. A module of interest that was preserved between datasets and corresponded with case\/control status was identified. This module was related to immune activation, specifically leukocyte activation, and was significantly increased in both CS lesions and DLE lesions compared to their respective controls. Protein-protein interaction (PPI) networks constructed for this module revealed seven common hub genes between CS lesions and DLE lesions: TLR1, ITGAL, TNFRSF1B, CD86, SPI1, BTK, and IL10RA. Common hub genes were highly upregulated in CS lesions and DLE lesions compared to their respective controls in a differential expression analysis. Our results indicate common gene expression patterns in the immune processes of CS and DLE, which may have indications for future therapeutic targets and serve as Th1-mediated disease biomarkers. Additionally, we identified hub genes unique to CS and DLE, which can help differentiate these diseases from one another and may serve as unique therapeutic targets and biomarkers. Notably, we find common gene expression patterns in the immune processes of CS and DLE through utilization of WGCNA.<\/jats:p>","DOI":"10.3389\/fmed.2020.606461","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T08:15:34Z","timestamp":1606292134000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Gene Co-expression Networks Identifies Common Hub Genes Between Cutaneous Sarcoidosis and Discoid Lupus Erythematosus"],"prefix":"10.3389","volume":"7","author":[{"given":"Melissa A.","family":"Nickles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Shin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Tsoukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadera J.","family":"Sweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia W.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"key":"B1","first-page":"1581","article-title":"Cutaneous sarcoidosis: a dermatologic masquerader","volume":"65","author":"Katta","year":"2002","journal-title":"Am Fam Physician"},{"key":"B2","volume-title":"Discoid lupus erythematosus","author":"Tanner","year":""},{"key":"B3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.berh.2013.07.008","article-title":"Cutaneous lupus erythematosus: diagnosis and treatment","volume":"27","author":"Okon","year":"2013","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cpm.2016.02.004","article-title":"Psoriasis: pathogenesis, assessment, and therapeutic update","volume":"33","author":"Schleicher","year":"2016","journal-title":"Clin Podiatr Med Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"F1000 Faculty Rev-1665","DOI":"10.12688\/f1000research.19144.1","article-title":"Psoriatic arthritis","volume":"8","author":"Ocampo","year":"2019","journal-title":"F1000Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/cmi.2012.15","article-title":"New insights of T cells in the pathogenesis of psoriasis","volume":"9","author":"Cai","year":"2012","journal-title":"Cell Mol Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e901","DOI":"10.1016\/j.jaad.2011.06.017","article-title":"Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway","volume":"66","author":"Judson","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/jid.2013.269","article-title":"Dominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis","volume":"134","author":"Jabbari","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4103\/0019-5154.139859","article-title":"Biologics in dermatology: an integrated review","volume":"59","author":"Sehgal","year":"2014","journal-title":"Indian J Dermatol."},{"key":"B11","first-page":"2129","article-title":"Tumor necrosis factor inhibition in the treatment of refractory sarcoidosis: slaying the dragon?","volume":"34","author":"Sweiss","year":"2007","journal-title":"J Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40257-019-00428-8","article-title":"Biologic therapy in the treatment of cutaneous sarcoidosis: a literature review","volume":"20","author":"Dai","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s11926-011-0180-z","article-title":"Treatment of cutaneous lupus","volume":"13","author":"Chang","year":"2011","journal-title":"Curr Rheumatol Rep."},{"key":"B14","first-page":"27","article-title":"Treatment of cutaneous lupus erythematosus: review and assessment of treatment benefits based on oxford centre for evidence-based medicine criteria","volume":"6","author":"Winkelmann","year":"2013","journal-title":"J Clin Aesthet Dermatol."},{"key":"B15","first-page":"278","article-title":"Diagnosis and management of psoriasis","volume":"63","author":"Kim","year":"2017","journal-title":"Can Family Physician."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e12932","DOI":"10.1111\/dth.12932","article-title":"Biologics in dermatology: what does the future hold?","volume":"32","author":"Yavuz","year":"2019","journal-title":"Dermatol Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1165\/rcmb.2017-0207OC","article-title":"A circulating micro-RNA signature serves as a diagnostic and prognostic indicator in sarcoidosis","volume":"58","author":"Ascoli","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1164\/rccm.201910-1909LE","article-title":"Declining pulmonary function in interstitial lung disease linked to lymphocyte dysfunction","volume":"201","author":"Schott","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"S421","DOI":"10.1513\/AnnalsATS.201707-564OT","article-title":"Disease burden and variability in sarcoidosis","volume":"14","author":"Gerke","year":"2017","journal-title":"Annals Am Thoracic Soc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinform."},{"key":"B21","author":"Miller","year":"2011","journal-title":"Meta-Analyses of Data From Two (or More) Microarray Data Sets"},{"key":"B22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12872-016-0217-3","article-title":"Weighted gene co-expression network analysis identifies specific modules and hub genes related to coronary artery disease","volume":"16","author":"Liu","year":"2016","journal-title":"BMC Cardiovascul Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible","volume":"45","author":"Szklarczyk","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e6555","DOI":"10.7717\/peerj.6555","article-title":"Identification of four hub genes associated with adrenocortical carcinoma progression by WGCNA","volume":"7","author":"Xia","year":"2019","journal-title":"PeerJ"},{"key":"B26","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1214\/16-AOAS920","article-title":"Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression","volume":"10","author":"Phipson","year":"2016","journal-title":"Ann Appl Stat"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1002\/art.11350","article-title":"Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares","volume":"48","author":"Amoura","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12026-012-8270-1","article-title":"TLR7 and TLR9 in SLE: when sensing self goes wrong","volume":"53","author":"Celhar","year":"2012","journal-title":"Immunol Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fphar.2014.00265","article-title":"Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment","volume":"5","author":"Celhar","year":"2014","journal-title":"Front Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00403-014-1483-5","article-title":"Association of FCGR2A-R\/H131 polymorphism with susceptibility to systemic lupus erythematosus among Asian population: a meta-analysis of 20 studies","volume":"306","author":"Li","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"B31","article-title":"CD86 Gene [Online]","year":"","journal-title":"Weizmann Institutue of Science"},{"key":"B32","year":"","journal-title":"NIH U.S. National Library of Medicine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.5114\/aoms.2014.47827","article-title":"Tumor necrosis factor inhibitors - state of knowledge","volume":"10","author":"Lis","year":"2014","journal-title":"Arch Med Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2147\/TCRM.S967","article-title":"Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis","volume":"4","author":"Callejas-Rubio","year":"2008","journal-title":"Therapeut Clin Risk Manage."},{"key":"B35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1874312901206010315","article-title":"Anti-tumor necrosis factor-\u03b1 induced systemic lupus erythematosus()","volume":"6","author":"Almoallim","year":"2012","journal-title":"Open Rheumatol J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3389\/fimmu.2017.01986","article-title":"Bruton's tyrosine kinase, a component of b cell signaling pathways, has multiple roles in the pathogenesis of lupus","volume":"8","author":"Satterthwaite","year":"2017","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13075-017-1500-0","article-title":"Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus","volume":"20","author":"Chalmers","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3389\/fimmu.2018.00518","article-title":"Innate immune responses in leprosy","volume":"9","author":"Pinheiro","year":"2018","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/JIR.S104790","article-title":"Toll-like receptor cascade and gene polymorphism in host-pathogen interaction in Lyme disease","volume":"9","author":"Rahman","year":"2016","journal-title":"J Inflamm Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1755-1536-3-20","article-title":"Investigation of Toll-like receptors in the pathogenesis of fibrotic and granulomatous disorders: a bronchoalveolar lavage study","volume":"3","author":"Margaritopoulos","year":"2010","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12929-018-0436-2","article-title":"Toll-like receptors in lupus nephritis","volume":"25","author":"Devarapu","year":"2018","journal-title":"J Biomed Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/aps.2015.91","article-title":"Toll-like receptors: potential targets for lupus treatment","volume":"36","author":"Wu","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"B44","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/01902140303786","article-title":"Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis","volume":"29","author":"Oltmanns","year":"2003","journal-title":"Exp Lung Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"34604","DOI":"10.1038\/srep34604","article-title":"Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus","volume":"6","author":"Godsell","year":"2016","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1165\/ajrcmb.17.1.2781","article-title":"Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L","volume":"17","author":"Nicod","year":"1997","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0165-2478(01)00324-8","article-title":"CC chemokine receptor 5 (CCR5) mRNA expression in pulmonary sarcoidosis","volume":"80","author":"Petrek","year":"2002","journal-title":"Immunol Lett"},{"key":"B48","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1164\/rccm.200412-1707OC","article-title":"C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis","volume":"172","author":"Spagnolo","year":"2005","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.606461\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T08:15:37Z","timestamp":1606292137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.606461\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":48,"alternative-id":["10.3389\/fmed.2020.606461"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.606461","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]},"article-number":"606461"}}